$2.16
-0.03-1.37%
At Close: -
$2.17
0.00770.36%
After Hours: Sep 20, 8:00 AM EDT
15 minutes delayed
Comments
Loading...
Latest news for Mersana Therapeutics (NASDAQ:MRSN) Stock
Mersana Therapeutics Stock (NASDAQ: MRSN)
Categories: All
Tuesday, August 27, 2024
Wednesday, August 14, 2024
Tuesday, August 13, 2024
Thursday, May 09, 2024
Wednesday, April 24, 2024
Tuesday, March 19, 2024
Friday, March 15, 2024
Thursday, February 29, 2024
- Mersana Therapeutics shares are trading highe...
- Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
- Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
- Wedbush Upgrades Mersana Therapeutics to Outp...
- Truist Securities Upgrades Mersana Therapeuti...
- Baird Maintains Neutral on Mersana Therapeuti...
- Guggenheim Upgrades Mersana Therapeutics to B...
Wednesday, February 28, 2024
Tuesday, February 27, 2024
Thursday, January 18, 2024
Friday, January 05, 2024
Thursday, December 21, 2023
Monday, December 04, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
Tuesday, October 31, 2023
Wednesday, September 06, 2023
Tuesday, August 08, 2023
Friday, July 28, 2023
Thursday, July 27, 2023
- Mersana Therapeutics shares are trading lower...
- Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Thursday
- Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results
- Why Mersana Therapeutics Stock Is Plunging Today?
- Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
- Wedbush Downgrades Mersana Therapeutics to Ne...
- Truist Securities Downgrades Mersana Therapeu...
- Dow Jumps 100 Points; US GDP Rises 2.4% In Q2